MediPharm Labs Corp trades with the ticker LABS on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Looking to invest in MediPharm Labs Corp? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
LABS.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $28.09MM
PE Ratio:
Price: 43.7 (Updated: 3/12/2024 0:47:16)
MediPharm Labs Corp (LABS) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how LABS.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- MediPharm Labs Corp (LABS) vs Aurora Cannabis Inc (ACB)
- LABS has higher EPS (-0.05 vs -79.2). ACB and LABS both have P/E’s under 0.
- MediPharm Labs Corp (LABS) vs Avicanna Inc (AVCN)
- LABS has higher EPS (-0.05 vs -0.17). AVCN and LABS both have P/E’s under 0.
- MediPharm Labs Corp (LABS) vs Bausch Health Companies Inc (BHC)
- LABS has higher EPS (-0.05 vs -2.18). BHC and LABS both have P/E’s under 0.
- MediPharm Labs Corp (LABS) vs Cardiol Therapeutics Inc (CRDL)
- LABS has higher EPS (-0.05 vs -0.43). CRDL and LABS both have P/E’s under 0.
- MediPharm Labs Corp (LABS) vs Cronos Group Inc (CRON)
- LABS has higher EPS (-0.05 vs -0.24). CRON and LABS both have P/E’s under 0.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability. Features a lower EV/EBITDA ratio (-1.36) than the industry average (0.33), indicating attractive valuation.
How to Buy LABS stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
